• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Fallopian Tube Diseases

Fallopian Tube Diseases - 17 Studies Found

Completed : Antispasmodic Drug for Diagnosis Proximal Tubal Occlusion on Hysterosalpingography
: Tubal Obstruction
: 2015-11-21
: Procedure: hysterosalpingography Starting procedure by using largest appropriate speculum for maximum ce
Completed : Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Peritoneal Cancer : 2016-11-22
    :
    • Procedure: Baseline Biopsy Bas

Completed : Hysteroscopic Tubal Occlusion Using Iso-Amyl 2-Cyano Acrylate (Amcrylate) in Patients With Hydrosalpinx
:
  • Hydrosalpinx
  • Infertility, Female

: 2016-11-23
: Drug: Isoamyl 2-Cyanoacrylate
Completed : Use of Essure® Micro-inserts in Women With Hydrosalpinx Prior to In Vitro Fertilization: A Prospective, Multicenter, International Feasibility Study
: Women Who Suffer From Hydrosalpinx That is Causing Infertility and Whom Want a Safer Way of Treamtent
: 2010-10-04
: Device: Essure Micro Insert
Completed : Prevalence of HbA1C in Women With PCOS
:
  • Polycystic Ovarian Syndrome
  • Pelvic Endometriosis
  • Insulin R
    : 2013-04-15
Completed : A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
:
  • Gynecologic Neoplasms
  • Epithelial Ovarian Cancer
  • Uterine En
    : 2016-03-31
    : Drug: Pembrolizumab Pembrolizumab 200mg IV Other Nam
Completed : A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer
:
  • Cancer Ovaries
  • Cancer Peritoneal
  • Cancer, Fallopian Tube : 2017-01-13
    :
    • Drug: OMP-305B83 intravenous (

Not yet recruiting : Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
:
  • Advanced Cancer
  • Ovarian Cancer
  • Primary Peritoneal Carcinom
    : 2017-01-20
    :
    • Drug: Pembrolizumab Given intr

Completed : Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients _MITO-23
: Ovarian Neoplasms
: 2016-08-26
:
  • Drug: Trabectedin Other Name:

Completed : A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers
:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Peritoneal Cancer : 2016-06-29
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.